8-epi PGF(2α) generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo

Circulation

Volumn 95, Issue 11, 1997, Pages 2492-2499

  Delanty, N ^a   Reilly, M P ^a   Pratico, D ^a   Lawson, J A ^a   McCarthy, J F ^c   Wood, A E ^c   Ohnishi, S T ^b   Fitzgerald, D J ^d   FitzGerald, G A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Philadelphia Biomedical Research Institute   (United States)

^c MATER PRIVATE HOSPITAL   (Ireland)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

free radicals; prostaglandins; reperfusion

Indexed keywords

CREATINE KINASE; FREE RADICAL; PROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; DRUG DERIVATIVE; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BYPASS SURGERY; CORONARY REPERFUSION; DOG; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HEART INFARCTION; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVASCULARIZATION; ADULT; AGED; ANIMAL; CORONARY ARTERY BYPASS GRAFT; ELECTRON SPIN RESONANCE; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; DINOPROST; DOGS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY;

EID: 0030610106     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.11.2492     Document Type: Article

References (59)

1. Wade CR, van Rij AM. Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxyradicals on the quantitation of plasma lipid peroxides. Life Sci. 1988;43:1085-1093.
2. Yamamoto Y, Frei B, Ames B. Assay of lipid hydroperoxides using high performance liquid chromatography with isoluninol chemiluminesenee detection. Methods Enzymol. 1990;186;371-380.
3. Coghlan J, Flitter W, Holley A, Norell M, Mitchell AG, Ilsley CD, Slater TF, Detection of free radicals and lipid hydroperoxides in blood taken from the coronary sinus of man during percutaneous transluminal coronary angioptasty. Free Radic Res. 1991;14:409-417.
4. Esterbauer H, Striegl G, Publ H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res. 1989,6:67-75.
5. Porter NA, Caldwell SB, Mills KA. Mechanisms of free radical activation of unsaturated lipids. Lipids. 1995;30:277-290.
6. Morrow JD, Harris TM, Roberts LJ II. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications, for measurement of eicosanoids. Anal Biochem. 1990; 184:1-10.
7. 2-like compounds are produced in vivo in humans by a non-cvclooxygenuse, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990;87:9383-9387.
8. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation. J Clin Invest. 1992;90: 2502-2507.
9. 2 receptors. J Clin Invent. 1992;90:136-141.
10. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264: 1619-1624.
11. 2α. J Biol Chem. 1995;270:9800-9808.
12. Davies SW, Ranjadayalan K. Wickens DC, Dorinandy TL, Tinunis AD. Lipid peroxidation associated with successful thrombolysis. Lancer. 1990;335:741-743.
13. Purvis J, Young L, Lightbody J, Trimble E, Adgey J. Free radical production following thrombolytic therapy in acute myocardial infarction. Circulation. 1992;86(suppl I):I-804. Abstract.
14. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation. 1989;80:1115-1127.
15. Loesser KE, Kukreja RC, Kazziha SY, Jesse RL, Hess ML. Oxidative damage to the myocardium: a fundamental mechanism of myocardial injury. Cardioscience, 1991:2:199-216.
16. Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of Superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol. 1986;250:H372-H377.
17. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of die spin trap α-phenyl N-tert-butyl nitrone. J Clin Invest. 1988;82:476-485.
18. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, McCay PB. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial 'stunning' is a manifestation of reperfusion injury, Circ Res, 1989;65:607-622.
19. Davies SW, Ranjadayalan K, Wickens DG, Dormandy TL, Umachandran V, Timmis AD. Free radical activity and left ventricular function after thrornbolysis for acute infarction. Br Heart J. 1993;69:114-120.
20. Bolli R. Myocardial 'stunning' in man. Circulation. 1992:86: 1671-1691.
21. Ferreira R, Llesuy S, Milei J, Scordo D, Hourquebie H, Molteni L, de Palma C, Boveris A. Assessment of myocardial oxidative stress in patients after myocardial revascularization. Am Heart J. 1988;115: 307-312.
22. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, Hardesty RL. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-1269.
23. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart disease in women. N Engl Med. 1993;328:1444-1449.
24. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
25. Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med 1993;328:1487-1489.
26. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins: benefits not yet proved. N Engl Med. 1994;330:1080-1081.
27. Stephens NG, Parsons PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996;347:781-786.
28. Fitzgerald DJ, Fragetta J, FitzGerald GA. Prostaglandin enderoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. J Clin Invest. 1988;82:1708-1713.
29. 2 in reocclusion following coronary thrombolysis with tissue type activator. Proc Natl Acad Sci USA. 1989;86:7583-7589.
30. Cathcart MK, Chisolm GM, McNally AK, Morel DW. Oxidative modification of low density lipoproteins (LDL) by activated monocytes and the cell lines U937 and HL60. In Vitro Cell Dev Biol. 1988;24:1001-1008.
31. Lowty OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent J Biol Chem. 1951;193:265-275.
32. luliano L, Pratico D, Ghiselli L, Bonvita MS, Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids. 1992;27:349-353.
33. Nourooz-Zadeh J, Taajaddini-Sarmandi J, Wolff SP. Measurement of plasma hydroperoxide concentration by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem. 1994;220:403-409.
34. Tortolani AJ, Powell SR, Misik V, Weglicki WB, Pogo GJ, Kramer JH. Detection of alkoxyl and carbon-centered free radicals in coroaary sinus blood from patients undergoing elective cardioplegia. Free Radic Biol Med. 1993;14:421-426.
35. Kramer JH, Misik V, Weglicki WB. Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat vitamin E affords protection. Free Radic Biol Med. 1994;16:713-723.
36. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, Roberts LJ II. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem. 1994;269:4317-4326.
37. Harrison KA, Murphy RC. Isoleukotrienes: biologically active free radical products of lipid peroxidation. J Biol Chem, 1995;270:17273-17278.
38. Pratico D, Lawson J, FitzGerald GA. Isothromboxane formation by human monocytes. Blood, 1995;86:509. Abstract.
39. 2 receptors in human platelets. J Pharmacol Exp Ther. 1994;270:1192-1196.
40. 2α is not mediated by thromboxane receptor isoforms. J Biol Chem. 1996;271:14916-14924.
41. 2 modulate the response to tissue-type plasminogen activator in vivo, Circ Res. 1989;65:83-94.
42. 2α specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Cli Pharmacol. 1996;42:15-19.
43. Reilly MP, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, l996;94;19-25.
44. Burk RF, Lawrence RA, Lane JM. Liver necrosis and lipid peroxidation in the rat as a result of paraquat and diquat administration: effects of selenium deficiency. J Clin Invest. 1980;5:1024-1031.
45. Loft S, Astrup A, Bueman B, Poulsen HE. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J. 1994;8:534-537.
46. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health, 1989;79:158-162.
47. 2α by human monocytes. J Biol Chem. 1996;271:8919-8924.
48. 2-isoprostanes during oxidation of human low-density lipoprotein and plasma, by peroxynitrite. Circ Res. 1995;77:335-341.
49. 2α: an index of oxidative stress to vivo. Circulation. l996:94(suppl I):I-277. Abstract.
50. FitzGerald GA, Pedersen AC, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation. 1983;67:l174-1177.
51. Pratico D, Basili B, Cordova C, Iuliano L, Ferro D, Camastra C. FitzGerald GA, Violi F. Increased oxidant stress in liver cirrhosis. J Invest Med. 1996;44:301A. Abstract.
52. 2-isoprastanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
53. 2α an index of oxidant stress, is increased during acute coronary angioplasty. Circulation. 1996;94(suppl I):I-638, Abstract.
54. 2α. J Pharmacol Exp Ther. 1995;275:94-100.
55. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy iidividuals who smoke cigarettes. Circulation, 1987;76:6-14.
56. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Platelet activation in vivo after intravenous streptokinase in patients with actue myocardial infarction. Circulation. 1988;77:142-150.
57. 2 in humans. Thromb Res. 1987;47:647-656.
58. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation. 1989;80: 1049-1062.
59. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol. 1993;21:537-545.